Poor outcomes and asthma hospitalisations: How important is asthma severity and how do we measure it?

Allergologia et Immunopathologia

Volumn 37, Issue 5, 2009, Pages 223-224

  Omachi, T A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; SHORT ACTING DRUG;

ALLERGIC ASTHMA; ARTIFICIAL VENTILATION; ASTHMA; ATOPY; CAUSAL ATTRIBUTION; CAUSE OF DEATH; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EDITORIAL; EXERCISE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HOSPITALIZATION; HUMAN; MEDICAL RESEARCH; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRESCRIPTION; RISK ASSESSMENT;

ADRENAL CORTEX HORMONES; ASTHMA; DISEASE PROGRESSION; HOSPITALIZATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY FUNCTION TESTS; RISK MANAGEMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 70350328023     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2009.06.007     Document Type: Editorial

References (14)

1. McFadden Jr. E.R., and Warren E.L. Observations on asthma mortality. Ann Intern Med 127 (1997) 142-147
2. McCoy K., Shade D.M., Irvin C.G., Mastronarde J.G., Hanania N.A., Castro M., et al. Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol 118 (2006) 1226-1233
3. Robertson C.F., Rubinfeld A.R., and Bowes G. Pediatric asthma deaths in Victoria: the mild are at risk. Pediatr Pulmonol 13 (1992) 95-100
4. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (2007), National Institutes of Health, Bethesda, MD
5. Hansen E.F., Vestbo J., Phanareth K., Kok-Jensen A., and Dirksen A. Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 (2001) 690-693
6. Omachi T.A., Iribarren C., Sarkar U., Tolstykh I., Yelin E.H., Katz P.P., et al. Risk factors for death in adults with severe asthma. Ann Allergy Asthma Immunol 101 (2008) 130-136
7. Eisner M.D., Katz P.P., Yelin E.H., Henke J., Smith S., and Blanc P.D. Assessment of asthma severity in adults with asthma treated by family practitioners, allergists, and pulmonologists. Med Care 36 (1998) 1567-1577
8. Guite H.F., Dundas R., and Burney P.G. Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma. Thorax 54 (1999) 301-307
9. Dales R.E., Nunes F., Partyka D., and Ernst P. Clinical prediction of airways hyperresponsiveness. Chest 93 (1988) 984-986
10. Malo J.L. Asthma may be more severe if it is work-related. Am J Respir Crit Care Med 172 (2005) 406-407
11. Des Roches A., Paradis L., Bougeard Y.H., Godard P., Bousquet J., and Chanez P. Long-term oral corticosteroid therapy does not alter the results of immediate-type allergy skin prick tests. J Allergy Clin Immunol 98 (1996) 522-527
12. Moore W.C., Bleecker E.R., Curran-Everett D., Erzurum S.C., Ameredes B.T., Bacharier L., et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 119 (2007) 405-413
13. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J 22 (2003) 470-477
14. Garcia-Aymerich J., Varraso R., Anto J.M., and Camargo Jr. C.A. Prospective study of physical activity and risk of asthma exacerbations in older women. Am J Respir Crit Care Med 179 (2009) 999-1003